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CASE REPORT
IMMUNOLOGICAL RESPONSE IN CASES OF COMPLICATED AND UNCOMPLICATED
BARTONELLOSIS DURING PREGNANCY
Erick HUARCAYA(1,2), Ciro MAGUINA(2), Ivan BEST(2), Nelson SOLORZANO(3) & Lawrence LEEMAN(1,4)
SUMMARY
Bartonellosis (Carrion’s Disease) during pregnancy is associated with high rates of maternal and perinatal mortality. We report
the immunological patterns in two cases of human bartonellosis during pregnancy. One patient had an uncomplicated course while
the second patient developed life threatening anasarca and cardiac tamponade. The patient with a complicated course had a Th1
response with a higher elevation of IL-10. This elevation has been associated with poor outcome pregnancies during bacterial
infections.
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INTRODUCTION
Infection with Bartonella sp. has been associated with Cat Scratch
Disease, Bacillary Angiomatosis, endocarditis, Bacillary Peliosis,
Carrion’s Disease, etc7. In Peru, Carrion’s Disease has been described
since the pre-Columbian cultures1. The female sandfly of the genus
Lutzomyia spp. is the vector of transmission12, and has been mainly
reported between 500 and 3200 meters of elevation12. The etiologic
agent of Carrion’s Disease is Bartonella bacilliformis, an aerobic,
pleomorphic and monopolar flagellated Gram-negative bacterium
which is surrounded by pilli and aggregative fimbriae11. These bacteria
may produce an acute infection (Oroya Fever) or chronic infection
(Peruvian Wart) with differing clinical presentations.
The acute or hematic phase is characterized by fever and a severe
hemolytic anemia with hepatosplenomegaly, jaundice and pallor. The
mortality of the acute phase varies between 1% in hospitalized patients
and 88% in untreated patients12.
During the acute phase, non-understood cellular immuno-
suppression predisposes patients with bartonellosis to secondary
infection and occurs due to transient alteration in T- lymphocyte number
and function, and is not accompanied by humoral immunodeficiency3,13.
Complications of Carrion’s Disease include myocarditis,
pericarditis, neurobartonellosis, and superimposed infection due to the
previously mentioned immunosuppression. Co-infections with
Salmonellas, toxoplasmosis, tuberculosis, pneumococcal pneumonia,
Pneumocystis carinii pneumonia, and Staphylococcus aureus sepsis
has been described4,8. Non-infectious complications include congestive
heart failure, thrombocytopenia, severe anemia, seizures, intracranial
hypertension, and multi-organ dysfunction4,8,12.
Neonatal and maternal mortality rates are high when the acute
phase of Carrion’s Disease occurs during pregnancy8,18. Trans-placental
infection has also been reported8. In one small case series, two of five
pregnant women with the acute phase of Bartonellosis died and two of
the remaining patients had a spontaneous abortion8.
The eruptive phase of Bartonellosis is characterized by the
development of either a single wart or hundreds of warts that may
resemble Bacillary Angiomatosis or Kaposi’s Sarcoma7,8,12. Among
three pregnant women with the eruptive phase, none of these patients
or their newborns had complications7.
CASES REPORTS
CASE 1: 27 year-old G2 P1 Hispanic female farmer, from Huaraz
(Ancash-Peru), at 16 weeks estimated gestational age by last menstrual
period presented with a one-month history of nausea, vomiting, malaise,
weakness, fever, jaundice and 12 kilogram weight loss. In Huaraz the
peripheral smear showed that 5% of red blood cells were infected. She
was initially treated with Ceftriaxone, Penicillin and Azithromycin
during seven days. Due to a partial response, the antibiotic treatment
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was modified to Chloramphenicol and Clindamycin during four days.
This patient subsequently developed diarrhea and hypotension requiring
transfer to a tertiary care hospital in Lima. On arrival the patient was
febrile, hypotensive, hypoxic, and had anasarca, with 40% of red blood
cells infected by B. bacilliformis. An echocardiogram revealed a cardiac
tamponade. Obstetric ultrasound showed a gestation of 18 weeks six
days, AFI = 31mm, FHT = 157/min. Patient had a pericardiotomy the
next day and 500 cc of hematic pericardic fluid was drained during 24
hours. The developed fever, hypotension and respiratory distress two
days later. The patient received Chloramphenicol, Clindamycin and
Ceftaxidime with improvement of clinical condition. The patient was
discharged after 15 days of hospitalization with resolution of her acute
phase Bartonellosis with no evidence of complications in the fetus.
She returned to Ancash, where no further follow-up was recorded. The
immunology markers evaluated during the admission showed a WBC
count of 31800 cel/µL, CD4+ recount of 2873 cel/µL, a CD4+/CD8+
ratio of 1.75, with very elevated values of INF-gamma (533.75 pg/
mL) and IL-10 (69.64 pg/mL). Those values decreased after treatment
including the CD4+, CD8+ recount, with a CD4+/CD8+ ratio of 0.66,
also decreased but still elevated values of INF-gamma (188.78 pg/mL)
and IL-10 (50.85 pg/mL) were found (Table 1).
CASE 2: 23 year-old G2P1 Hispanic female from Caraz (Ancash-
Peru), G2 P1-0-0-1, at 13 weeks estimated gestational age by LMP,
presented with a three month history of malaise, headache, emesis,
osteo-mio-arthicular mild pain, diaphoresis and fever. The patient had
a blood smear obtained in the emergency room, which demonstrated
Bartonella bacilliformis in 1% of red blood cells. She received
intravenous Ceftriaxone for seven days, without reduction in the
proportion of infected red blood cells. Patient received an additional
six days of treatment with subsequent eradication of B. bacilliformis
in the red blood cell smear. She was discharged with resolution of her
uncomplicated, acute phase of Human Bartonellosis. She subsequently
delivered of 3150 grams infant with Apgar scores of 5 and 9 at 39
weeks. The immunology markers evaluated during the acute phase
showed normal values for WBC count (6200 cel/µL), CD4+ recount
(780 cel/µL), CD4+/CD8+ ratio (2.57), INF-γ (18.75 pg/mL) and IL-
10 (12.07 pg/mL). After treatment, a mild increase of the WBC, CD4+,
and CD8+, with a CD4+/CD8+ ratio of 2.35 was found. Also only a
mild increase in the anti-inflammatory cytokines was noted (Table 1).
METHOD
Samples were collected in two local hospitals in the department of
Huaraz, Peru. Cases were confirmed according guidelines of the
Peruvian Ministry of Health, using peripheral smear and blood culture,
in both cases. Each specimen was collected in a 10 mL vacutainer tube
with EDTA®, and send immediately to Lima to their analysis. All the
samples arrived to the laboratory in less than 12 hours.
The immunological studies were done in the Instituto de Medicina
Tropical “Alexander von Humboldt” (IMT-AvH), of the Universidad
Peruana Cayetano Heredia. The absolut recount of T cells CD4+/ T
cells CD8+ were performed in total peripheric blood using Flow-Count
(Coulter®). The samples were analyzed using the program CELLQuest
in a Cytometer FACSCalibur (Becton Dickinson®). The production of
IFN-γ, TNF-α, IL-4, and IL-10, were evaluated in the plasma of each
patient. Commercial Kits were used (BD OptEIATM ELISA Kits®). The
concentration of cytokines (pg/mL) was measured using an “Elisa
Reader” (Biorad®).
DISCUSSION
We have presented two cases of acute phase of Carrion’s Disease
during pregnancy and for the first time their immunology response
pattern during the acute phase at the moment of their admission and a
second pattern during their recovery before to be discharged from the
hospital. It is well known that during pregnancy, the evolution of the
acute phase of Human Bartonellosis has a high incidence of adverse
poor maternal and fetal outcomes. There is a high incidence of
miscarriage after the acute infection of Bartonella bacilliformis4,7,8,18,
although the etiology is unclear.
Pregnancy may potentially alter the regulation of the inflammatory
response to Bartonellosis. Immunoglobulin synthesis in pregnant
women is increased, whereas cell-mediated response is decreased,
which may allow increase susceptibility to intracellular pathogens
during pregnancy16. During pregnancy, progesterone-induced blocking
factor (PIBF) is released and mediates the immunomodulatory and
anti-abortive effect of progesterone due to the production of Th2 type
cytokines2,5. High levels of IL-4, IL-6, IL-10 and PIBF have been
founded in health pregnant women, and increased IL-2, INF-gamma,
and low expression on PIBF and IL-10, in those pregnancies with high
risk for prematurity or recurrent spontaneous miscarriage14,15,17.
In the first case, the patient with complicated course of Carrion’s
Disease, showed an increase of pro-inflammatory cytokines. During
pregnancy Th1 cytokines may be harmful, as TNF-α has been
demonstrated to inhibit trophoblast cell proliferation. In patients with
severe sepsis, the measure of IL-1 and TNF-α correlates negatively
with the survival rate of the patient2,15,16. Those cytokines are expressed
mainly in the Th1 response. The pro-inflammatory response may be a
Table 1
Immunological pattern in two cases of Bartonellosis during pregnancy at the acute phase (AP) and post resolution of the infection (PI)
Patient Moment WBC CD4+ CD8+ CD4/CD8 IFN-γ TNF-α IL-4 IL-10
of study (cel/µL) (cel/µL) (cel/µL) (pg/mL) (pg/mL) (pg/mL) (pg/mL)
Case 1 AP 31800 2873.93 1643.26 1.75 533.75 1.09 0.00 69.64
PI 12050 492 745 0.66 188.78 0.00 0.00 50.85
Case 2 AP 6200 780 310 2.57 18.75 0.91 2.33 12.07
PI 7850 1190 506 2.35 20.63 2.99 11.47 18.90
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cause of miscarriage during severe infections of Bartonella
bacilliformis, as was observed in other gram negative infections2,5.
The second patient with uncomplicated acute phase of Carrion’s
Disease did not demonstrate an increase in Th1 cytokines but did have
an increased level of the Th2 cytokine IL-4.
Both patients showed and elevation of IL-10, but it was most evident
in the patient with the complicated course. Elevation of IL-10 is due
mainly by T cells CD43+ CD4+, which are important cells in the
equilibrium of the Th1 or Th2 response6,14. Th2 cytokines, including
IL-10, inhibit the secretion of Th1 cytokines16, and as previously
mentioned may have “anti-abortive effect” in a normal pregnancy.
However, high levels of IL-10 had been reported in patients with severe
sepsis, mainly by gram-negative organism9,10, as a response to the effect
of inflammatory cytokines, and this may produce an “immunological
paralysis” of antigen presenting cells, and macrophages. This
phenomenon may explain the more severe course of Human
Bartonellosis in some patients, and deserves further study.
CD4+ T cell recount were within normal range in both patients.
This may indicate that the hypothesized decrease in cell-mediated
immunity response in pregnant women with Bartonella bacilliformis
infection is due to a dysfunction in the cell mediated response rather
than a loss of the number of T cells involved in this response.
Our results showed that the patient that developed the complicated
course had mainly a Th1 response, with elevation of pro-inflammatory
cytokines that is associated with poor outcome pregnancies. The patient
who developed a non-complicated course, showed a mild elevation of
pro inflammatory and elevated anti-inflammatory cytokines. In both
cases, IL-10, an anti-inflammatory cytokine, was elevated but more
prominently in the complicated patient, and the possibility that an
“immunological paralysis” phenomenon occurred in Human
Bartonellosis deserves further investigation.
RESUMEN
Respuesta inmunologica en casos de bartonelosis con y sin
complicaciones durante el embarazo
Bartonelosis (Enfermedad de Carrión) durante el embarazo esta
asociado a una alta tasa de mortalidad maternal y perinatal. Reportamos
el perfil inmunológico de dos casos de Bartonelosis humana en el
embarazo. Una paciente tuvo un curso sin complicaciones, mientras la
segunda presento complicaciones severas de anasarca y tamponamiento
cardiaco. La paciente con curso complicado tuvo un patrón de repuesta
Th1, con una elevación de IL-10, que se ha asociado a mal pronóstico
en infecciones durante embarazo.
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